Dr. Maitri Kalra
Claim this profileSinai Hospital of Baltimore
Studies Breast Cancer
Studies Cancer
8 reported clinical trials
24 drugs studied
Area of expertise
1Breast Cancer
ER positive
HER2 positive
Stage IV
2Cancer
HER2 positive
ER positive
PR positive
Affiliated Hospitals
Clinical Trials Maitri Kalra is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
More about Maitri Kalra
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Maitri Kalra has experience with
- Paclitaxel
- Usual Care Disease Monitoring
- Serum Tumor Marker Directed Disease Monitoring
- Trastuzumab
- Pertuzumab
- Radiation
Breakdown of trials Maitri Kalra has run
Breast Cancer
Cancer
Recurrence
Progesterone Receptor Positive
Tumor Markers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maitri Kalra specialize in?
Maitri Kalra focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are HER2 positive.
Is Maitri Kalra currently recruiting for clinical trials?
Yes, Maitri Kalra is currently recruiting for 8 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Maitri Kalra has studied deeply?
Yes, Maitri Kalra has studied treatments such as Paclitaxel, Usual care disease monitoring, Serum Tumor Marker directed disease monitoring.
What is the best way to schedule an appointment with Maitri Kalra?
Apply for one of the trials that Maitri Kalra is conducting.
What is the office address of Maitri Kalra?
The office of Maitri Kalra is located at: Sinai Hospital of Baltimore, Baltimore, Maryland 21215 United States. This is the address for their practice at the Sinai Hospital of Baltimore.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.